Showing 1,512 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental hepatitis C treatment

Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France

Editor's pick
Bloomberg
4 April 2011
People with limited treatment options

Cipla seeks voluntary license for anti-HIV Isentress

Editor's pick
Moneycontrol.com
4 April 2011
People with limited treatment options

Cipla seeks voluntary license for anti-HIV Isentress

Editor's pick
4 April 2011
Pharmaceutical industry

U.S. jury rejects Glaxo antitrust claims vs Abbott

Editor's pick
Reuters
31 March 2011
New & experimental HIV treatments

Once-daily nevirapine approved in United States

News
29 March 2011
Treatment guidelines

Conflicts of Interest Common Among Guideline Writers

Editor's pick
MedPage Today
29 March 2011
New & experimental HIV treatments

US meeting on HIV drug gives Avexa a boost

Editor's pick
The Australian
28 March 2011
Pharmaceutical industry

California Urges Gilead Sciences to Cut Aids Drug Prices

Editor's pick
Pharmaceutical Technology
25 March 2011
Pharmaceutical industry

Glaxo Accuses Abbott of Stifling Competition on AIDS Drug

Editor's pick
25 March 2011
Pharmaceutical industry

Glaxo Accuses Abbott of Stifling Competition on AIDS Drug

Editor's pick
Bloomberg
25 March 2011
Pharmaceutical industry

Glaxo says Abbott improperly hiked price of HIV drug

Editor's pick
CNBC
24 March 2011
Pharmaceutical industry

Abbott settles HIV pricing claims with pharmacies

Editor's pick
CNBC / Reuters
23 March 2011
Pharmaceutical industry

J&J, U.S. Sue Teva to Block Generic Version of Prezista HIV Drug

Editor's pick
Bloomberg
19 March 2011
Epidemiology

UNAIDS, activists urge countries to get clever with TRIPS

Editor's pick
IRIN Plus News
17 March 2011
New & experimental hepatitis C treatment

Who will win the hepatitis C market?

Editor's pick
Seeking Alpha
15 March 2011
New & experimental HIV treatments

HIV drug firm Koronis Pharmaceuticals eyes London listing

Editor's pick
Daily Telegraph
14 March 2011
New & experimental HIV treatments

Gilead's High Bar for AIDS Drugs Means New Development Withers

Editor's pick
San Francisco Chronicle
14 March 2011
Clinical trials

Meta-analyses cagey about funding sources/affiliations, review finds

Editor's pick
Pharma Times
11 March 2011
HIV treatment for children & young people

Tentative approval for abacavir sulfate scored tablets for oral suspension, 60 mg

Editor's pick
PharmaLive
10 March 2011
Government, leadership & policy

Canada: Commons passes bill to send generic drugs to developing countries

Editor's pick
Montreal Gazette
10 March 2011
Pharmaceutical industry

HIV/AIDS Update - Tentative approval for Lamivudine and Tenofovir DF Fixed Dose Combination Tablets, 300 mg/300 mg

Editor's pick
PharmaLive
10 March 2011
HIV treatment

Glaxo Seeks $1.5 Billion in AIDS Drug Trial Against Abbott

Editor's pick
Bloomberg
1 March 2011
New & experimental HIV treatments

Attachment inhibitor BMS-663068 potent and well-tolerated in early study

News
1 March 2011
PrEP

Gilead's $12000-a-Year HIV Prevention Pill Fails to Win Physician Support

Editor's pick
Bloomberg
28 February 2011